Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ramirent in connection with its acquisition of JIAB
Mandate

Vinge advises Ramirent in connection with its acquisition of JIAB

March 21, 2023 Banking and Finance M&A Corporate Commercial IT, Telecommunications and Outsourcing Intellectual Property Real Estate and Construction

Vinge advises Ramirent AB in connection with its acquisition of JIAB Hyrcenter (consisting of the companies JIAB Hyrcenter AB and JIAB Boden AB). Ramirent thereby further strengthens its position in Norrbotten and as the largest machine rental company in Sweden.

Vinge’s team mainly consist of Jonas Johansson, Per Kling, Elsie Nassar and Nando Basic (M&A), Arvid Axelryd and Emma Gustavsson (IPR), Seyran Sahin and Ida Redander (Banking and finance), Anna Ståhlklo, Anna Högsten and Maja Eliasson (Employment), Martin Boström and Mario Saad (Corporate commercial), Karolina Fuhrman and Elis Allmark (IT & GDPR), Tove Tullberg and Julia Löfqvist (compliance), Rebecka Maltenius (real estate), and Emy Rydén and Ellinore Boström Andersson (project assistants).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026